v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income    
Revenue $ 1,398,000 $ 0
Cost of revenue (1,281,000) 0
Gross Profit 117,000  
Selling, general and administrative 1,415,000 427,000
Total 1,415,000 427,000
Operating loss (1,298,000) (427,000)
Total other income (expense)    
Interest income (expense) 4,000 3,000
Total other (expense) 4,000 3,000
Net loss (1,294,000) (424,000)
Net loss attributable to Elite Health Systems Inc. $ (1,294,000) $ (424,000)
Basic and diluted net loss per share attributable to Elite Health Systems Inc. (in dollars per share) $ (0.05) $ (0.02)
Weighted average common shares outstanding, basic and diluted (in shares) 28,521,620 21,082,146